KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 118 filers reported holding KITE PHARMA INC in Q4 2014. The put-call ratio across all filers is 1.96 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $335,000 | -76.0% | 4,263 | -86.3% | 0.01% | -73.5% |
| Q4 2016 | $1,395,000 | +216.3% | 31,111 | +252.9% | 0.03% | +277.8% |
| Q2 2016 | $441,000 | +90.1% | 8,817 | +74.1% | 0.01% | +28.6% |
| Q1 2016 | $232,000 | -55.2% | 5,063 | -39.8% | 0.01% | -22.2% |
| Q4 2015 | $518,000 | +87.7% | 8,410 | +85.4% | 0.01% | +80.0% |
| Q2 2015 | $276,000 | -24.4% | 4,535 | -28.4% | 0.01% | -16.7% |
| Q4 2014 | $365,000 | – | 6,337 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |